The estimated Net Worth of Robert Stefanovich is at least $2.15 Milion dollars as of 25 March 2024. Mr. Stefanovich owns over 1,079 units of CryoPort Inc stock worth over $999,714 and over the last 10 years he sold CYRX stock worth over $41,150. In addition, he makes $1,110,520 as Chief Financial Officer, Treasurer oraz Corporate Secretary at CryoPort Inc.
Robert has made over 13 trades of the CryoPort Inc stock since 2016, according to the Form 4 filled with the SEC. Most recently he sold 1,079 units of CYRX stock worth $18,926 on 25 March 2024.
The largest trade he's ever made was exercising 135,036 units of CryoPort Inc stock on 21 November 2019 worth over $414,561. On average, Robert trades about 15,219 units every 116 days since 2014. As of 25 March 2024 he still owns at least 128,333 units of CryoPort Inc stock.
You can see the complete history of Mr. Stefanovich stock trades at the bottom of the page.
Robert S. Stefanovich is the Chief Financial Officer, Treasurer, Corporate Secretary of the Company. In 2019, he was also given the title Senior Vice President. From 2011 to 2019, Mr. Stefanovich served as the Secretary of the Company. From June 15, 2012 to November 4, 2012, Mr. Stefanovich served as the Principal Executive Officer of the Company. From November 2007 through March 2011, Mr. Stefanovich served as Chief Financial Officer of Novalar Pharmaceuticals, Inc., a venture-backed specialty pharmaceutical company. Prior to that, he held several senior positions, including interim Chief Financial Officer of Xcorporeal, Inc., a publicly traded medical device company, Executive Vice President and Chief Financial Officer of Artemis International Solutions Corporation, a publicly traded software company, Chief Financial Officer and Secretary of Aethlon Medical Inc., a publicly traded medical device company and Vice President of Administration at SAIC, a Fortune 500 company. Mr. Stefanovich also served as a member of the Software Advisory Group and an Audit Manager with Price Waterhouse LLP’s (now PricewaterhouseCoopers) hi-tech practice in San Jose, CA and Frankfurt, Germany. He currently also serves as a board member of Project InVision International, a provider of business performance improvement solutions. He received his Master of Business Administration and Engineering from University of Darmstadt, Germany.
As the Chief Financial Officer, Treasurer oraz Corporate Secretary of CryoPort Inc, the total compensation of Robert Stefanovich at CryoPort Inc is $1,110,520. There are 2 executives at CryoPort Inc getting paid more, with Jerrell Shelton having the highest compensation of $3,839,460.
Robert Stefanovich is 54, he's been the Chief Financial Officer, Treasurer oraz Corporate Secretary of CryoPort Inc since 2018. There are 8 older and no younger executives at CryoPort Inc. The oldest executive at CryoPort Inc is Richard Berman, 77, who is the Lead Independent Director.
Robert's mailing address filed with the SEC is C/O CRYOPORT INC., 112 WESTWOOD PLACE, SUITE 350, BRENTWOOD, TN, 37027.
Over the last 12 years, insiders at CryoPort Inc have traded over $202,268,038 worth of CryoPort Inc stock and bought 80,292 units worth $196,910 . The most active insiders traders include Holdings Ii L.P.Blackstone ..., Richard J Berman oraz Jerrell Shelton. On average, CryoPort Inc executives and independent directors trade stock every 39 days with the average trade being worth of $414,958. The most recent stock trade was executed by Robert J Hariri on 19 August 2024, trading 1,000 units of CYRX stock currently worth $9,470.
cryoport delivers an innovative and complete outsourced frozen shipping solution for biological materials. this breakthrough combination replaces outdated dry ice shipping, virtually eliminates the risk of cell degradation and revolutionizes deep frozen logistics. we combine the technology of liquid nitrogen dry vapor shippers with the most advanced logistics management platform in the industry. when added with our logistics expertise, we provide a complete outsourced solution that advances deep-frozen shipping for the life science community. whether your business is bio-pharmaceuticals, clinical trials, research or reproductive medicine, you want to focus on your core mission. cryoport will help you transport life.
CryoPort Inc executives and other stock owners filed with the SEC include: